Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
quality control
Pharma
MilliporeSigma plugs €62M into new quality control building
Despite some growing pains in the post-COVID era, Merck KGaA's MilliporeSigma continues to make a splash with big production moves this year.
Fraiser Kansteiner
Jun 14, 2024 10:00am
China's Hengrui hit with Form 483 for manufacturing shortfalls
Jun 6, 2024 9:29am
FDA slams 3 Indian drugmakers in flurry of recent Form 483s
Apr 16, 2024 8:45am
The FDA serves up warning letters to pair of Indian pharmas
Apr 10, 2024 9:58am
China's API firm Sichuan Deebio in deep trouble with the FDA
Feb 12, 2024 2:46pm
Catalent's Indiana filling plant in hot water with the FDA again
Feb 7, 2024 2:11pm
